404 related articles for article (PubMed ID: 35671803)
1. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
Morgan E; Soerjomataram I; Rumgay H; Coleman HG; Thrift AP; Vignat J; Laversanne M; Ferlay J; Arnold M
Gastroenterology; 2022 Sep; 163(3):649-658.e2. PubMed ID: 35671803
[TBL] [Abstract][Full Text] [Related]
2. Global incidence of oesophageal cancer by histological subtype in 2012.
Arnold M; Soerjomataram I; Ferlay J; Forman D
Gut; 2015 Mar; 64(3):381-7. PubMed ID: 25320104
[TBL] [Abstract][Full Text] [Related]
3. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study.
Zhang Y; Vaccarella S; Morgan E; Li M; Etxeberria J; Chokunonga E; Manraj SS; Kamate B; Omonisi A; Bray F
Lancet Oncol; 2023 Nov; 24(11):1206-1218. PubMed ID: 37837979
[TBL] [Abstract][Full Text] [Related]
4. Global trends in esophageal cancer.
Malhotra GK; Yanala U; Ravipati A; Follet M; Vijayakumar M; Are C
J Surg Oncol; 2017 Apr; 115(5):564-579. PubMed ID: 28320055
[TBL] [Abstract][Full Text] [Related]
5. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
6. Global burden of oesophageal and gastric cancer by histology and subsite in 2018.
Arnold M; Ferlay J; van Berge Henegouwen MI; Soerjomataram I
Gut; 2020 Sep; 69(9):1564-1571. PubMed ID: 32606208
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020.
Zhu H; Wang Z; Deng B; Mo M; Wang H; Chen K; Wu H; Ye T; Wang B; Ai D; Hao S; Tseng I; Zhao K
Thorac Cancer; 2023 Apr; 14(11):992-1003. PubMed ID: 36918204
[TBL] [Abstract][Full Text] [Related]
8. Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.
Arnold M; Colquhoun A; Cook MB; Ferlay J; Forman D; Soerjomataram I
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):90-7. PubMed ID: 26494763
[TBL] [Abstract][Full Text] [Related]
9. Global trends in esophageal cancer mortality with predictions to 2025, and in incidence by histotype.
Santucci C; Mignozzi S; Malvezzi M; Collatuzzo G; Levi F; La Vecchia C; Negri E
Cancer Epidemiol; 2023 Dec; 87():102486. PubMed ID: 37956470
[TBL] [Abstract][Full Text] [Related]
10. Esophageal cancer in Canada: trends according to morphology and anatomical location.
Otterstatter MC; Brierley JD; De P; Ellison LF; Macintyre M; Marrett LD; Semenciw R; Weir HK
Can J Gastroenterol; 2012 Oct; 26(10):723-7. PubMed ID: 23061066
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study.
Cattelan L; Ghazawi FM; Le M; Lagacé F; Savin E; Zubarev A; Gantchev J; Tomaszewski M; Sasseville D; Waschke K; Litvinov IV
Cancer Med; 2020 Jan; 9(1):401-417. PubMed ID: 31715645
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
Arnold M; Laversanne M; Brown LM; Devesa SS; Bray F
Am J Gastroenterol; 2017 Aug; 112(8):1247-1255. PubMed ID: 28585555
[TBL] [Abstract][Full Text] [Related]
14. Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise.
Lander S; Lander E; Gibson MK
Curr Gastroenterol Rep; 2023 Nov; 25(11):275-279. PubMed ID: 37812328
[TBL] [Abstract][Full Text] [Related]
15. Global burden of primary liver cancer in 2020 and predictions to 2040.
Rumgay H; Arnold M; Ferlay J; Lesi O; Cabasag CJ; Vignat J; Laversanne M; McGlynn KA; Soerjomataram I
J Hepatol; 2022 Dec; 77(6):1598-1606. PubMed ID: 36208844
[TBL] [Abstract][Full Text] [Related]
16. Trends in esophageal cancer incidence by histology, United States, 1998-2003.
Trivers KF; Sabatino SA; Stewart SL
Int J Cancer; 2008 Sep; 123(6):1422-8. PubMed ID: 18546259
[TBL] [Abstract][Full Text] [Related]
17. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Morgan E; Soerjomataram I; Gavin AT; Rutherford MJ; Gatenby P; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Jackson C; Kozie S; Little A; Møller B; Shack L; Tervonen H; Thursfield V; Vernon S; Walsh PM; Woods RR; Finley C; Merrett N; O'Connell DL; Reynolds JV; Bray F; Arnold M
Gut; 2021 Feb; 70(2):234-242. PubMed ID: 32554620
[TBL] [Abstract][Full Text] [Related]
18. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040.
Zhang Y; Rumgay H; Li M; Yu H; Pan H; Ni J
J Glob Health; 2023 Sep; 13():04109. PubMed ID: 37712386
[TBL] [Abstract][Full Text] [Related]
19. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
González Ortiz DI; Toro DH
Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
[TBL] [Abstract][Full Text] [Related]
20. Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.
Ji J; Hemminki K
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):840-5. PubMed ID: 16678496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
